Indometacin farnesil

From Wikipedia, the free encyclopedia
  (Redirected from Indomethacin farnesil)
Jump to: navigation, search
Indometacin farnesil
Indometacin farnesil.svg
Clinical data
AHFS/ International Drug Names
Routes of
ATC code
  • None
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Metabolism To indometacin
Biological half-life 1.5 hours
Excretion Renal
CAS Number
PubChem CID
Chemical and physical data
Formula C34H40ClNO4
Molar mass 562.14 g/mol
3D model (JSmol)

Indometacin farnesil (INN) is a prodrug of the nonsteroidal anti-inflammatory drug (NSAID) indometacin, designed to reduce the occurrence of side-effects by esterification of the carboxyl group on indometacin with farnesol. Indometacin farnesil was first approved in Japan in 1991, and is available in Japan and Indonesia, under the trade names Infree and Dialon, respectively.

External links[edit]